We are live on ! Find out more
PSC

Prentiss Smith & Co Portfolio holdings

AUM $182M Turnover 8.7%
1-Year Est. Return 26.44%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+26.44%
3 Year Est. Return
+63.89%
5 Year Est. Return
+57.29%
10 Year Est. Return
+270.92%
AUM
$191M
AUM Growth
+$14.8M
Cap. Flow
+$4.27M
Cap. Flow %
2.23%
Top 10 Hldgs %
47.22%
Holding
271
New
28
Increased
29
Reduced
43
Closed
22
Avg Time Held
2.3 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
1.5 years

Top Buys

Rank Stock Value
1
FFIV icon
F5
FFIV
+$5.25M
2
UMPQ
Umpqua Holdings Corp
UMPQ
+$4.89M
3
ORCL icon
Oracle
ORCL
+$2.77M
4
FSLR icon
First Solar
FSLR
+$2.04M
5
GILD icon
Gilead Sciences
GILD
+$467K

Sector Composition

Rank Sector Weight
1 Healthcare 26.37%
2 Technology 20.77%
3 Communication Services 15.92%
4 Industrials 11.33%
5 Financials 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DBO icon
226
Invesco DB Oil Fund
DBO
$313M
$1K ﹤0.01%
100
– –
2013 Q2
16 quarters
MOS icon
227
The Mosaic Company
MOS
$5.96B
$1K ﹤0.01%
31
– –
2013 Q2
16 quarters
TBT icon
228
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$327M
$1K ﹤0.01%
6
– –
2017 Q1
1 quarter
AIOT icon
229
PowerFleet Inc
AIOT
$310M
$1K ﹤0.01%
100
– –
2013 Q2
16 quarters
YTEN icon
230
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
– –
0
– –
2013 Q2
16 quarters
ALXN
231
DELISTED
Alexion Pharmaceuticals
ALXN
$1K ﹤0.01%
9
-391
-98% -$45.5K
2013 Q4
14 quarters
RDC
232
DELISTED
Rowan Companies Plc
RDC
$1K ﹤0.01%
140
– –
2013 Q2
16 quarters
ILG
233
DELISTED
ILG, Inc Common Stock
ILG
$1K ﹤0.01%
40
-80
-67% -$2.03K
2016 Q2
4 quarters
AZN icon
234
AstraZeneca
AZN
$256B
– –
-723
Closed -$45K –
CMG icon
235
Chipotle Mexican Grill
CMG
$37.7B
– –
-7,500
Closed -$67K –
DE icon
236
Deere & Co
DE
$172B
– –
-100
Closed -$11K –
INTU icon
237
Intuit
INTU
$86.3B
– –
-124
Closed -$14K –
MGA icon
238
Magna International
MGA
$17.6B
– –
-172,460
Closed -$7.44M –
PHO icon
239
Invesco Water Resources ETF
PHO
$1.94B
– –
-100
Closed -$3K –
REGN icon
240
Regeneron Pharmaceuticals
REGN
$81.3B
– –
-751
Closed -$291K –
SFM icon
241
Sprouts Farmers Market
SFM
$6.07B
– –
-12,891
Closed -$298K –
TGT icon
242
Target
TGT
$69.8B
– –
-4,677
Closed -$258K –
VFC icon
243
VF Corp
VFC
$6.62B
– –
-64
Closed -$3K –
VHT icon
244
Vanguard Health Care ETF
VHT
$19.8B
– –
-180
Closed -$25K –
AMJ icon
245
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
– –
-425
Closed -$14K –
CAJ
246
DELISTED
Canon, Inc.
CAJ
– –
-300
Closed -$9K –
CPL
247
DELISTED
CPFL Energia S.A.
CPL
– –
-157
Closed -$3K –
EEP
248
DELISTED
Enbridge Energy Partners
EEP
– –
-1,000
Closed -$19K –
BIVV
249
DELISTED
Bioverativ Inc. Common Stock
BIVV
– –
-167
Closed -$9K –
SWC
250
DELISTED
Stillwater Mining Co
SWC
– –
-1,000
Closed -$17K –

Similar funds

Prentiss Smith & Co's Q2 2017 Portfolio in Review

As of Q2 2017, Prentiss Smith & Co held 271 positions worth $191M, up 8.4% from $176M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Prentiss Smith & Co's Q2 2017 filing shows 28 new, 29 increased, 43 reduced and 22 closed positions. Its largest new stake was Gilead Sciences: 7,018 shares worth $497K. The largest sale was Magna International, an estimated $7.44M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Communication Services.

  • Prentiss Smith & Co's largest Q2 2017 buy was Gilead Sciences: 7,018 shares worth $497K.
  • Prentiss Smith & Co added most to F5 in Q2 2017, an estimated $5.25M increase.
  • Prentiss Smith & Co's biggest Q2 2017 reduction was Whole Foods Market Inc, cutting an estimated $3.12M.
  • Prentiss Smith & Co fully exited Magna International in Q2 2017, selling an estimated $7.44M.
  • Prentiss Smith & Co's ten largest holdings make up 47% of its $191M portfolio in Q2 2017.
  • Prentiss Smith & Co opened 28 new positions and closed 22 in Q2 2017.
  • Prentiss Smith & Co's portfolio value rose 8.4% quarter-over-quarter to $191M.

Based on Prentiss Smith & Co's 13F filing for Q2 2017, filed 10 Jul 2017.